survivor
[대역어] None
[용어속성] Term
[용어속성] Term
Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China
Research Paper
[키워드] Abnormalities
analyzed
change
Chest CT
chest CT scan
Clinical data
clinical feature
collected
coronavirus disease
correlated
COVID-19
D-dimer level
erythrocyte sedimentation rate
feature
final cohort
information
lactate dehydrogenase
lymphocyte
Lymphocyte count
Mortality
mortality rate
neutrophil
Neutrophil-to-lymphocyte ratio
nonsurvivors
not different
Older
outcome
Patient
patients with COVID-19
positively correlated
prognostic
prognostic indicator
Radiographic
rationale
Result
risk factor
scored
significantly
survivor
Survivors
symptom onset
Union Hospital
Viral pneumonia
while
Wuhan
Wuhan, China
X-ray computed tomography
[DOI] 10.7150/thno.46569 PMC 바로가기 [Article Type] Research Paper
[DOI] 10.7150/thno.46569 PMC 바로가기 [Article Type] Research Paper
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
Original Investigation
[키워드] 95% CI
association
Cohort
confounder
coronavirus disease
COVID-19
COVID-19 patients
death group
Deceased
diabetes
evaluate
Glucose
hospital
increased risk
inflammatory factors
insulin resistance
marker
Mild
morbidity
Mortality
outcome
Patient
patients died
patients with COVID-19
Regression
Result
Severe case
severe cases
severity
significantly
significantly higher
statistically significant
survivor
Triglyceride
TyG index
were used
Wuhan
[DOI] 10.1186/s12933-020-01035-2 PMC 바로가기 [Article Type] Original Investigation
[DOI] 10.1186/s12933-020-01035-2 PMC 바로가기 [Article Type] Original Investigation
Considerations for Postacute Rehabilitation for Survivors of COVID-19
Viewpoint
[키워드] acute respiratory syndrome
asked
Care
caused
cognitive
Comorbidities
Complication
coronavirus
COVID-19
discharge
disease
Effect
geriatric
help
hospital
Infection
Infectious disease
inpatient rehabilitation
intensive care
intubation
mental health
neurological
outcomes
pathology
Patient
patient outcome
patients with COVID-19
public health
Quality of life
question
recovery
rehabilitation
reported
Respiratory system
SARS-CoV-2
second
subacute care
suggested
survivor
Survivors
therapy
Treatment
virus
[DOI] 10.2196/19462 PMC 바로가기 [Article Type] Viewpoint
[DOI] 10.2196/19462 PMC 바로가기 [Article Type] Viewpoint
Are COVID-19 survivors at increased risk for suicide?
Letter to the Editor
[키워드] COVID-19
increased risk
survivor
[DOI] 10.1017/neu.2020.21 PMC 바로가기 [Article Type] Letter to the Editor
[DOI] 10.1017/neu.2020.21 PMC 바로가기 [Article Type] Letter to the Editor
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China
Research
[키워드] Acute kidney injury
age
analyzed
case sery
characterized
China
clinical
Clinical course
Clinical data
clinically
Coagulopathy
collected
coronavirus
coronavirus disease
cough
Course
COVID-19
COVID-19 patient
COVID-19 patients
Critical
death
described
discharged
discharged patient
distress
dominant
Dyspnea
enrolled
Factor
Fever
Gender
hospital
illness onset
independent risk factor
Infection
Leukocytosis
lymphopenia
male
Male sex
mild case
mild cases
multi-organ dysfunction
myocardial injury
non-survivor
Novel coronavirus
outbreak
outcome
Patient
Platelet
Pneumonia
Prognosis
pulmonary infiltrates
radiological
reported
resolved
Result
SARS-CoV-2
Severe case
severe cases
Shock
survivor
syndrome
systemic symptom
university
Week
with COVID-19
Wuhan
Wuhan, China
[DOI] 10.1186/s13054-020-02895-6 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13054-020-02895-6 PMC 바로가기 [Article Type] Research
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Article
Published on
Journal: Clinical chemistry and laboratory medicine
[Category] meta-analysis, SARS, 바이오마커, 변종, 비임상, 신약개발, 유전자 메커니즘, 임상, 치료기술, 치료법, 치료제,
Journal: Clinical chemistry and laboratory medicine
[Category] meta-analysis, SARS, 바이오마커, 변종, 비임상, 신약개발, 유전자 메커니즘, 임상, 치료기술, 치료법, 치료제,
[키워드] 95% CI
95% confidence interval
abnormality
analyzed
biochemical
Biomarker
China
clinician
CNKI
Coagulation
Cohort
coronavirus disease
COVID-19
Critical
disease
distress
elevated
evaluate
fatal COVID-19
fatal disease
form
hematologic
hospitalized patient
identify
IL-10
IL-6
immune
Inflammation
Infrastructure
Injury
interleukin
Kidney function
Laboratory
laboratory abnormality
Laboratory parameters
liver
lymphocyte
Lymphocyte count
marker
mean difference
measure
Meta-analysis
MONITOR
Mortality
non-survivor
pandemic
parameter
Patient
patients with COVID-19
Platelet
predictor
progression
risk stratification
Serum ferritin
severe disease
severity
significantly
significantly increased
survivor
Survivors
the disease
was performed
WBC
Web of Science
while
White blood cell
[DOI] 10.1515/cclm-2020-0369 PMC 바로가기
[DOI] 10.1515/cclm-2020-0369 PMC 바로가기
COVID-19 and smoking: A systematic review of the evidence
Editorial
[키워드] 2019 novel coronavirus
2019-nCoV
Admission
adverse outcome
adverse outcomes
Analysis
association
assumed
autonomous
available data
calculate
Care
changes in
Characteristics
chest radiology
China
clinical
Clinical characteristics
Clinical outcome
clinical symptom
clinically
cohort study
conducted
coronavirus
Course
COVID-19
COVID-19 pandemic
current
database
death
deaths
detrimental
diagnosed
died
discharged
disease
Disease progression
English
epidemiological
evaluate
Evidence
Factor
feature
FIVE
former
Health
hospital
hospitalisation
hospitalised patient
Hospitalization
humans
ICU
ICU care
immune system
inclusion criteria
Increases
indicated
individual
infected with COVID-19
infected with SARS-CoV-2
infections
Infectious disease
Influenza
information
Inpatient
intensive care
Italy
Laboratory
laboratory-confirmed
Logistic regression
Logistic regression analysis
lung
majority
mechanical ventilation
MERS-CoV
Mortality
mortality risk factor
multicenter cohort study
multicentre
multivariate
multivariate logistic regression
negative
non-ICU
non-severe patient
non-survivor
outbreak
outcome
pandemic
Patient
patients
patients died
patients with COVID-19
percentage
plethora
Population
positive
previous study
Prognosis
Prognostic factor
progression
proportion
Prospective
provided
pulmonary
ranged
Region
regions
reported
Research
Respiratory disease
retrieved
retrospective
retrospective cohort study
risk factor
Sample size
searched
setting
Severe case
Severe patient
severe symptom
severe symptoms
severity
shown
significantly higher
small sample size
smoker
Smokers
smoking
smoking status
statistical analysis
statistically significant
statistically significant difference
Study design
study population
Support
survived
survivor
Symptom
Symptoms
systematic review
table
tested
the disease
the patient
those that survived
title
Tobacco
two group
were excluded
were used
with COVID-19
Wuhan
Wuhan, China
[DOI] 10.18332/tid/119324 PMC 바로가기 [Article Type] Editorial
[DOI] 10.18332/tid/119324 PMC 바로가기 [Article Type] Editorial
Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia
Research
[키워드] aligned
Antibody Response
Antibody therapeutics
asymptomatic infections
clinical manifestations
collected
conducted
Coronavirus infections
cough
Diabetes Mellitus
died
Dynamics
enrolled
hospital
ill patient
infection control
information
Kinetics
Laboratory
Medical conditions
MERS
MERS-CoV
MERS-CoV RNA
Middle East
Middle East respiratory syndrome
Mortality
Neutralizing
Patient
peaked
respiratory
respiratory infections
respiratory syndrome coronavirus
respiratory tract
response
reverse transcription PCR
RNA
robust
Saudi Arabia
serologic testing
serum antibody response
specimen
survivor
upper respiratory
Vaccines
Viral load
virus clearance
viruses
[DOI] 10.3201/eid2504.181595 PMC 바로가기 [Article Type] Research
[DOI] 10.3201/eid2504.181595 PMC 바로가기 [Article Type] Research
Critically ill healthcare workers with the middle east respiratory syndrome (MERS): A multicenter study
Research Article
[키워드] 95% CI
baseline
clinical care
Clinical course
Critical
Critically ill
Critically ill patient
demographics
ECMO therapy
finding
functional
HCW
HCWs
healthcare worker
hospital discharge
Hospital mortality
inclusion criteria
Intervention
investigated
limitations
MERS
MERS case
MERS-CoV
Middle East
multicenter
Non-survivors
Outbreaks
outcome
outcomes
PaO2/FiO2 ratio
Patient
performance
questionnaire
receive
renal impairment
respiratory
retrospective cohort study
scale
status
survivor
Survivors
syndrome
Transmission
were recorded
[DOI] 10.1371/journal.pone.0206831 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0206831 PMC 바로가기 [Article Type] Research Article